Serengulam V. Govindan

Person

Summit, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Dosages of immunoconjugates of antibodies and SN-38 for improved ef...
- Patent number 11,541,047
- Issue date Jan 3, 2023
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy...
- Patent number 11,192,955
- Issue date Dec 7, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number RE48751
- Issue date Sep 28, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
Information Patent Grant
Antibody-drug conjugates and uses thereof
- Patent number 11,116,846
- Issue date Sep 14, 2021
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 11,077,201
- Issue date Aug 3, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 11,066,468
- Issue date Jul 20, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapy for metastatic urothelial cancer with the antibody-drug con...
- Patent number 11,052,081
- Issue date Jul 6, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates and uses thereof
- Patent number 11,052,156
- Issue date Jul 6, 2021
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 11,020,489
- Issue date Jun 1, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosages of immunoconjugates of antibodies and SN-38 for improved ef...
- Patent number 10,918,721
- Issue date Feb 16, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates and uses thereof
- Patent number 10,849,986
- Issue date Dec 1, 2020
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-SN-38 immunoconjugates with a CL2A linker
- Patent number 10,751,420
- Issue date Aug 25, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inh...
- Patent number 10,744,129
- Issue date Aug 18, 2020
- Immunomedics, Inc.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2...
- Patent number 10,709,701
- Issue date Jul 14, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosages of immunoconjugates of antibodies and SN-38 for improved ef...
- Patent number 10,682,347
- Issue date Jun 16, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates and uses thereof
- Patent number 10,653,793
- Issue date May 19, 2020
- Immunomedics, Inc.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 10,561,738
- Issue date Feb 18, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapy for metastatic urothelial cancer with the antibody-drug con...
- Patent number 10,413,539
- Issue date Sep 17, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 10,322,193
- Issue date Jun 18, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 10,280,220
- Issue date May 7, 2019
- IBC Pharmaceuticals, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 10,265,414
- Issue date Apr 23, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy...
- Patent number 10,266,605
- Issue date Apr 23, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL...
- Patent number 10,206,918
- Issue date Feb 19, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RS7 antibodies
- Patent number 10,179,171
- Issue date Jan 15, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-SN-38 immunoconjugates with a CL2A linker
- Patent number 10,143,756
- Issue date Dec 4, 2018
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosages of immunoconjugates of antibodies and SN-38 for improved ef...
- Patent number 10,137,196
- Issue date Nov 27, 2018
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-drug conjugates and uses thereof
- Patent number 10,130,718
- Issue date Nov 20, 2018
- Immunomedics, Inc.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dosages of immunoconjugates of antibodies and SN-38 for improved ef...
- Patent number 10,130,626
- Issue date Nov 20, 2018
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunoconjugates with an intracellularly-cleavable linkage
- Patent number 10,064,957
- Issue date Sep 4, 2018
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-SN-38 immunoconjugates with a CL2A linker
- Patent number 10,034,950
- Issue date Jul 31, 2018
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240398954
- Publication date Dec 5, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240398955
- Publication date Dec 5, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...
- Publication number 20240352146
- Publication date Oct 24, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...
- Publication number 20240352148
- Publication date Oct 24, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20240350474
- Publication date Oct 24, 2024
- IMMUNOMEDICS, INC.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...
- Publication number 20240352145
- Publication date Oct 24, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...
- Publication number 20240352147
- Publication date Oct 24, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CON...
- Publication number 20240180892
- Publication date Jun 6, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240148873
- Publication date May 9, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240139324
- Publication date May 2, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER
- Publication number 20230233694
- Publication date Jul 27, 2023
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20220054648
- Publication date Feb 24, 2022
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CON...
- Publication number 20210393617
- Publication date Dec 23, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...
- Publication number 20210395385
- Publication date Dec 23, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE
- Publication number 20210346511
- Publication date Nov 11, 2021
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20210069343
- Publication date Mar 11, 2021
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20210046185
- Publication date Feb 18, 2021
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20200316054
- Publication date Oct 8, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunoconjugates with an Intracellularly-Cleavable Linkage
- Publication number 20200276325
- Publication date Sep 3, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20200246481
- Publication date Aug 6, 2020
- Immunomedics, Inc.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunoconjugates with an Intracellularly-Cleavable Linkage
- Publication number 20200121805
- Publication date Apr 23, 2020
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20200085968
- Publication date Mar 19, 2020
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CON...
- Publication number 20190381032
- Publication date Dec 19, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunoconjugates with an Intracellularly-Cleavable Linkage
- Publication number 20190194318
- Publication date Jun 27, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...
- Publication number 20190177427
- Publication date Jun 13, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunoconjugates with an Intracellularly-Cleavable Linkage
- Publication number 20190167805
- Publication date Jun 6, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RS7 Antibodies
- Publication number 20190083621
- Publication date Mar 21, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EFFICACY OF ANTI-HLA-DR ANTIBODY DRUG CONJUGATE IMMU-140 (hL243-CL2...
- Publication number 20190083487
- Publication date Mar 21, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20190070308
- Publication date Mar 7, 2019
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER
- Publication number 20190030175
- Publication date Jan 31, 2019
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Serengulam V. Govindan

Person

Patents Grantslast 30 patents

Dosages of immunoconjugates of antibodies and SN-38 for improved ef...

Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy...

Immunoconjugates with an intracellularly-cleavable linkage

Antibody-drug conjugates and uses thereof

Immunoconjugates with an intracellularly-cleavable linkage

Immunoconjugates with an intracellularly-cleavable linkage

Therapy for metastatic urothelial cancer with the antibody-drug con...

Antibody-drug conjugates and uses thereof

Immunoconjugates with an intracellularly-cleavable linkage

Dosages of immunoconjugates of antibodies and SN-38 for improved ef...

Antibody-drug conjugates and uses thereof

Antibody-SN-38 immunoconjugates with a CL2A linker

Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inh...

Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2...

Dosages of immunoconjugates of antibodies and SN-38 for improved ef...

Antibody-drug conjugates and uses thereof

Immunoconjugates with an intracellularly-cleavable linkage

Therapy for metastatic urothelial cancer with the antibody-drug con...

Immunoconjugates with an intracellularly-cleavable linkage

Immunoconjugates with an intracellularly-cleavable linkage

Immunoconjugates with an intracellularly-cleavable linkage

Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy...

Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL...

RS7 antibodies

Antibody-SN-38 immunoconjugates with a CL2A linker

Dosages of immunoconjugates of antibodies and SN-38 for improved ef...

Antibody-drug conjugates and uses thereof

Dosages of immunoconjugates of antibodies and SN-38 for improved ef...

Immunoconjugates with an intracellularly-cleavable linkage

Antibody-SN-38 immunoconjugates with a CL2A linker

Patents Applicationslast 30 patents

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CON...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CON...

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...

IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

Immunoconjugates with an Intracellularly-Cleavable Linkage

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

Immunoconjugates with an Intracellularly-Cleavable Linkage

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CON...

Immunoconjugates with an Intracellularly-Cleavable Linkage

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY...

Immunoconjugates with an Intracellularly-Cleavable Linkage

RS7 Antibodies

EFFICACY OF ANTI-HLA-DR ANTIBODY DRUG CONJUGATE IMMU-140 (hL243-CL2...

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER